AstraZeneca said Wednesday that results from an analysis of a U.S. trial show its vaccine is safe and 76 percent effective against symptomatic Covid-19. Earlier this week, federal health officials questioned the company's previously reported 79 percent efficacy rate, saying that it may have been based on "outdated information." |
No comments:
Post a Comment